The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States

The American Journal of Gastroenterology
Miguel R ArguedasAaron A Stinnett

Abstract

Hepatitis A vaccination is recommended for patients with chronic hepatitis C. Our aim was to analyze the cost-effectiveness of hepatitis A vaccination in these patients. The specific strategies evaluated were: no vaccination, targeted vaccination, and universal vaccination. Clinical estimates were based on published data. Costs estimates were based on published data and institutional Medicare reimbursement rates. Health-related quality-of-life weights were derived from published data and expert estimates. The target population consisted of patients 45 yr of age with chronic hepatitis C followed every 6 months until death. We adopted a societal perspective. Compared with no vaccination, targeted vaccination was associated with an incremental cost-effectiveness ratio of $51,000 per quality-adjusted life-year. The incremental cost-effectiveness ratio of universal vaccination compared with targeted vaccination was $3,900,000 per quality-adjusted life-year. The results were particularly sensitive to the incidence of hepatitis A, probability of fulminant hepatic failure, and costs of hepatitis A antibody screening and vaccination. Targeted vaccination for hepatitis A in patients with chronic hepatitis C may be a cost-effective strate...Continue Reading

References

Oct 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P GinésJ M Salmerón
Jan 1, 1989·International Journal of Technology Assessment in Health Care·G W Torrance, D Feeny
Oct 13, 1988·The New England Journal of Medicine·UNKNOWN North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices
Jan 1, 1983·Medical Decision Making : an International Journal of the Society for Medical Decision Making·J R Beck, S G Pauker
Oct 1, 1993·Medical Decision Making : an International Journal of the Society for Medical Decision Making·F A Sonnenberg, J R Beck
Oct 9, 1996·JAMA : the Journal of the American Medical Association·L B RussellM C Weinstein
Dec 1, 1996·Digestive Diseases and Sciences·C Bréchot
Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·E B KeeffeD S Krause
Mar 21, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M H Sjogren
Jan 6, 1999·JAMA : the Journal of the American Medical Association·J B WongS G Pauker
Oct 26, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Z M YounossiK M Shermock
Mar 25, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R P MyersP J Marotta
Aug 10, 2000·Medical Decision Making : an International Journal of the Society for Medical Decision Making·R A HirthW G Weissert
Oct 13, 2000·American Journal of Public Health·J B WongT Poynard
May 8, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R K Avery, J Dumot
Nov 25, 2004·Clinics in Liver Disease·L B Seeff
May 1, 1997·Clinics in Liver Disease·T D Boyer
Jun 29, 2012·Circulation. Cardiovascular Quality and Outcomes·Duminda N WijeysunderaMark D Neuman

❮ Previous
Next ❯

Citations

Jan 30, 2004·The New England Journal of Medicine·Allen S Craig, William Schaffner
Sep 27, 2003·Journal of American College Health : J of ACH·R Jake JacobsAllen S Meyerhoff
Oct 17, 2008·American Journal of Public Health·Peter J NeumannJennifer A Palmer
Aug 29, 2003·Expert Opinion on Biological Therapy·Elisabetta FrancoMassimo Maurici
Nov 8, 2005·The American Journal of Medicine·Kathleen BockholdChantil Jeffreys
Nov 13, 2007·Vaccine·C T BauchM D Krahn
Aug 27, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maria Sjogren
Dec 25, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Philip Rosenthal
Nov 30, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Raymond S Koff
Jun 6, 2009·The American Journal of Gastroenterology·Bridget HernandezRamsey Cheung
Aug 23, 2005·Digestive Diseases and Sciences·R Jake JacobsSammy Saab
Aug 17, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael ShimEdmund J Bini
Mar 1, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ian A RoweDavid J Mutimer
Dec 20, 2012·Current Gastroenterology Reports·Michael D Leise, Jayant A Talwalkar
Feb 27, 2004·Addiction·Katherine M ConigraveJohn B Whitfield
Apr 28, 2004·Southern Medical Journal·Brian L Pearlman
Aug 9, 2003·Revista Da Sociedade Brasileira De Medicina Tropical·Fausto E L Pereira, Carlos S Gonçalves
Feb 11, 2005·Current Opinion in Gastroenterology·Richard H Moseley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.